Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech

114 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering medicine by harnessing metabolism in the DNA damage response One-carbon therapeutics AB is developing first-in-class MTHFD1/2 inhibitors of one-carbon metabolism, representing a novel way of attacking the DNA damage response (DDR) and targeting cancer.

60 similar entities Type: Startup Activities: deeptech cleantech greentech Technologies: Synthetic Biology Decarbonization

Brain Computer Interface Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale brain computer interface, neuroprosthesis, neuromodulation, neuromonitoring, neurotechnology, medtech, biotech, machine learning, and signal processing

77 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Nuuron is developing a Digital Drug to treat Alzheimer’s Disease. Nuuron is a VC backed, clinical stage neurotech company that develops the Memory-Pacemaker, a non-invasive, photonic neurostimulation to re-enable patients with Alzheimer's Disease to store and recall memories again.

57 similar entities Type: Startup Activities: it services Technologies: Synthetic Biology

Enabling next-generation neural implants with advanced semiconductor technology. We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to provide the best possible outcomes for patients with neurological conditions by delivering the highest performance with the least invasive surgery. Our team brings together world-class experts in neuroscience, microtechnology, and implantable neural interfaces — augmented with medtech industry pedigree and clinical experience. Semiconductors, Neural Implants, Brain-Computer Interfaces, Microelectronics, Medical Devices, Neural Interfaces, Neuromodulation, Neuromonitoring, and Neuroprosthetics

83 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Syntropic transforms depression care with light-based treatment Syntropic is developing HAVEN, a non-invasive brain stimulation device that restores neuroplasticity to treat depression. By delivering precise pulsed light stimulation, HAVENTM activates microglia, the brain’s immune cells, to remodel extracellular structures that block neuroplasticity. Syntropic’s technology is based on pioneering discovery by our scientific co-founders Prof. Sandra Siegert and Dr. Alessandro Venturino at ISTA, Institute of Science and Technology Austria.

60 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.

78 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Advanced Biomaterials for Regenerative Medicine Tensive is a biomedical company developing advanced biomaterials for regenerative medicine applications, with a current focus on reconstructive surgery after breast cancer.

77 similar entities Type: Startup Activities: deeptech healthtech Technologies: New Materials Synthetic Biology

Health Research & Development Center BIONOVEO offers project leaders, whether they are industrial or academic, the skills and biological, technical and methodological resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes.

169 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Galvani Bioelectronics is a joint venture between GSK and Verily Life Sciences. We are devoted to the development of life changing neuromodulation therapies for patients with chronic disease. Medical Devices

103 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Developing best-in-class NNMT inhibitors with a dual therapeutic effect to benefit patients with metabolic syndrome Cantoni Therapeutics is a biopharmaceutical spinout company from the University of Leiden (NL) developing best-in-class inhibitors of a single enzyme with a dual therapeutic effect to benefit patients with metabolic syndrome.

128 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We accompany companies with a complete service of Preclinical Trials and Clinical Trials of safety and efficacy GOYA INNOVA is a Spanish laboratory with 50 years of experience, specialized in preclinical and clinical evaluations of safety and efficacy for cosmetic, health products and food supplements.⁣ We manage 55,000 samples annually, and with our partners, we offer a comprehensive service.⁣ Our differential model of preclinical and clinical research integrates a CRO with its own Medical and Medical-Aesthetic Center.⁣ With more than 40 doctors of different specialties, we can:⁣ • Carry out studies under the highest quality standards⁣ • Optimize costs and …

289 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Parkinson's disease, Biased agonism, Orphan Drug, Autism, and Serotonin

179 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Late clinical stage company focused on drug discovery and development for the treatments of rare disorders of the CNS For additional information: info@sombiotech.com Pre-clinical validation, Licensing, In silico screening, Rare Diseases, Drug repurposing, Orphan CNS indications, Central Nervous System, Intellectual Property, and Artificial Intelligence

288 similar entities Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology

Creating a new path for neurodegenerative diseases Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition. alzheimer, terapia genica, gene therapy , disruptive therapy, Alzheimer´s Disease, Biomarker, neurodegenerative disease, neuroscience, neurociencia, enfermedades neurodegenerativas, neurodegeneration, dementia, and pioneering

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We turn medical devices into clinical reality neo-bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. Offering end-to-end medical device prototype development, from initial concept and rapid prototyping to pre-clinical testing and first-in-human prototypes for clinical trials

180 similar entities Type: Startup Activities: deeptech healthtech biotech manufacturing Technologies: Synthetic Biology

Doing the extraordinary to restore the ordinary Amber Therapeutics was founded in 2021 with a mission to develop and deliver breakthrough neuromodulation therapies that can fundamentally transform outcomes in areas of unmet clinical need. With the acquisition of Finetech Medical Limited and Bioinduction Ltd in 2023, we are continuing to be the only UK based company in the field of designing and manufacturing long-term implantables. We have since grown into a multidisciplinary team, combining deep medical device experience with a culture and mindset focused on transformational innovation. Amber UI is the company’s first therapy, aiming to restore normal physiological function …

105 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company which aims to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic effectiveness implemented. Sirius NeoSight uses breakthrough patented technology from a consortium of academic laboratories with expertise in the field.

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Designer and manufacturer of medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. DIXI medical design and manufactures medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. Epilepsy, SEEG, and Electrodes

62 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Stent'Up vise à sécuriser le traitement préventif des anévrismes cérébraux par la création d'un implant révolutionnaire. Stent Up, designs, manufactures, and markets medical devices dedicated to the treatment of strokes.

75 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, …

198 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

Nevezyne develops its own protein expression systems and offers its expertise in the expression of recombinant proteins, for research programs, for diagnosis in animal and human health Protein Expression, Baculovirus System, Protein Purification, and Bacterial System

219 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Nano Life Sciences Cementic, is biotech startup (Paris, France/Palo Alto, USA). Specializing in cutting-edge nano-biotechnology solutions with a focus on the dental field. Medtech, Biotech, Dental, Orthopedics, Nanotechnolgies, Stem cells , and Liposomes

118 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Intracellular delivery and neuroprotection — two patented technologies from Institut Pasteur research. Neurophoenix is a preclinical-stage biotechnology company arising from academic research carried out at Institut Pasteur. It holds two complementary patented technologies. VHH_NPX is a single-domain antibody engineered to cross two barriers that stop most therapeutics: the blood–brain barrier, and then the plasma membrane of the neuron itself — releasing its cargo directly into the cytosol rather than leaving it trapped in the endosomal compartment. NVshort is a short neuroprotective and neuroregenerative peptide, derived from a rabies virus glycoprotein motif, which selectively inactivates the PTEN–MAST2 interaction and reactivates the …

76 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

Nano Drug Solutions Revolutionizing neuropathy treatment Development of innovative nanomedicines targeting neuropathies, with a particular focus on hereditary neuropathies such as Charcot-Marie-Tooth disease Biothechnology

150 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Innovative digital therapies to support chronic diseases Easydeasy is a company that develops web applications aimed at supporting patients suffering from chronic illnesses in order to limit the risk of negative developments and detect them early.

52 similar entities Type: Startup Activities: deeptech

Reinvent the traceability of implantable medical devices to democratize and simplify clinical follow-up Our mission: Build secured and protected global Medical Device Health Registry by collecting data at the point of use in the Operating Room for practicing evidence-based medicine and tracing implantable devices to protect patient safety and meet regulatory compliance. Traçabilité, Santé, Prothèses, Dispositifs médicaux, Implants, DMI, IUD, DM, Wiki, Bloc opératoire, GS1, UDI, and Wiki

346 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Inovative company specialized in the development and manufacture of medical devices EOVE develops and manufactures innovatives products to improve care and quality life with greater freedom for Adult ans Pediatric Patients who suffer from breathing disorders and chronic respiratory diseases.

167 similar entities Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology

The ELEMENT Biotechnology is an innovative medical device health company focused on developing new solutions THE ELEMENT Biotechnology is a Medtech company based out of 9, Boulevard Gambetta, 38000, Grenoble, FRANCE Dispositifs médicaux, Biotechnologie, Medtech, Maladies neurodégénératives , Santé, Parkinson, and Innovation

220 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Pain relief at the touch of a finger Ethimedix is a healthcare technology company that offers a patented and pragmatic solution to fight against opioid misuse and dependence. Our flagship product, the SmartBottle, is a secure and efficient alternative to Opioid pills and PCA (PatientControlled Analgesia) pumps, utilizing biometric technology to dispense oral liquid opioids safely.

91 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

MDinc is a developer of neurological and cognitive AI-powered products MDinc is a modern medtech company, the developer of neurological and cognitive AI-powered products. We encompass solutions for people with nervous system disorders by coupling computer vision, machine learning and medical expertise to provide personalized digital therapies. NeuroTech, Healthcare, and MedTech

142 similar entities Type: Startup Activities: deeptech Technologies: A.I.

Company specialized in developing new and advanced materials solutions for skin-interacting medical devices BestHealth4U is a company dedicated to the research and development of new and advanced material technologies for skin-interacting medical devices.

106 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Follow us at Shionogi Inc. for news about our rare disease research programs https://www.linkedin.com/company/shionogi-inc-/ drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss

364 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aesyra SA is a spin-off of EPFL created in November 2017 in close collaboration with medical experts from the Clinique Universitaire de Médecine Dentaire de Genève (CUMD). Aesyra’s mission is to develop, manufacture and commercialize a medical device able to accurately monitor the jaw activity of the patient during sleep and provide an active bio-feedback to reduce teeth grinding without waking-up the patient.

69 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Pioneering a new era in precision medicine for women's health A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health. ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare

301 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology A.I.

Carvolix is a French medical technologies company, commercial and clinical stage, founded by Truffle Capital, that aims to become a global leader in the treatment of structural heart diseases and strokes, world's leading causes of mortality and disability. Carvolix develops novel AI and imaging driven mini-robots that make complex procedures doble by interventional cardiologists, as well as biomimetics heart valves.

65 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients.

153 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Fighting chronic and fatal diseases Tirecat Health is a company developing a family of novel polymers with amazing potential in the healthcare field. We are propelled with purpose to fight chronic and fatal diseases affecting patients worldwide using our revolutionary technology to improve their quality of life. In order to make this purpose a reality, the company is preparing to move towards the clinical phase to demonstrate the astonishing results seen in preclinical trials.

300 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Targeting Ultra-Rapid, Durable Remissions In Depression (NASDAQ: GHRS) GH Research plc (NASDAQ: GHRS) is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

59 similar entities Type: Startup Activities: deeptech

NESA MEDTECH PRIVATE LIMITED is a medical device startup working towards excellence in the Research & Development of Medical devices for emerging countries specifically India, and believes in pursuing business through innovation and technology. This is focused on delivering minimally invasive therapeutic devices innovation to address social and economic burden. NESA MEDTECH is mentored and supported by Department of Biotechnology, Government of India and Karnataka Biotechnology and information technology services.

78 similar entities Type: Incubators & VCs Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Multimodal diagnostic and therapeutic platform for the Neuro ICU Syncath Neurosience is focused on diagnostics and therapeutics for brain edema and elevated intracranial pressure such as in traumatic brain injuries, subarachnoid hemorrhage and intracranial hemorrhage

71 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology SaaS

Dairy Done Differently Imagindairy, a Foodtech company, is addressing the industry bottleneck by integrating deep tech with system biology to develop a commercial and viable animal free protein-based dairy product

73 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP

209 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Neuromodulation Simplified Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body. The primary focus is on treatments for chronic pain. Neuromodulation, DRG, Chronic Pain, PNS, and Stimulation

193 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Affordable high-end neuroimaging We make and sell brain imaging systems showing neural activity called magnetoencephalographs (MEG). We democratize the use of MEG, using a space technology, to effectively detect brain defects and improve brain cares MEG, medical device, and functional imaging

84 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

INNERVATE. SCREEN. TRANSLATE. NETRI is an Techbio industrial start-up whose mission is to improve human health through the discriminating power of the nervous system. The company offers a Neuron-as-a-sensor suite (NaaS) to gain insights into the safety and efficacy of clinical or chemical compounds. NETRI focuses on pain quantification and pursues an exploratory pipeline in oncology-related adverse events, dermo-cosmetics, neurological disorders and neurotoxicity. Leveraging the natural capacity of neurons to encode biological interactions into electrical impulses, the NaaS suite features the world-first compartmentalized electrophysiology platform in standard 96-well plate format - NeuroFluidicsTM MEA - which acts as a data generation …

92 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients.

84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

349 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Game-changer therapies for incurable axonal transport defects HuntX Pharma has been incorporated in december 2022 with the objective of being Pionneer and Leader in addressing new therapeutical targets to fight axonal transport defect related diseases with Huntington disease as a first indication. #HuntXPharma

59 similar entities Type: Startup Activities: biotech healthtech deeptech

Quest for Brain Health At BRAIN.Q (BrainQ technologies) we are on a Quest to provide a breakthrough, evidence-based Brain Health Therapeutics platform, addressing the ultimate frontier that will dictate the course of how we live and age.

63 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Affective Computing

Heart valves for life, for patients of any age, including children Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com Heart Valves and Medical Devices

62 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Providing cancer patients with a longer and better life Atonco is a clinical-stage radiopharmaceutical company developing innovative radiopharmaceutical products using astatine-211, an alpha-emitting radionuclide for the treatment of cancer. Atonco, founded in 2019, built with an experienced and passionate team, has exclusive global licenses for the use of an innovative proprietary antibody and radiolabeling technology.

68 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Minimally Invasive, Maximally Precise. DeepPulseNeuro is pioneering a new path in epilepsy care through endovascular brain monitoring, delivering greater precision, faster diagnosis, and renewed hope for cure.

59 similar entities Type: Startup Activities: deeptech healthtech

Overcoming Challenges, Innovating Hope An innovative molecule to reshape the future of the brain Glyx Therapeutics is dedicated to transforming the lives of patients by pioneering innovative treatments for neurodegenerative disorders with urgent, unmet medical needs. Our work focuses on tackling orphan tauopathies and Alzheimer’s disease, bringing hope and solutions to those facing these challenging conditions.

174 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Innovative disease modifying treatment for Parkinson's patients Synuca Therapeutics combines decades of groundbreaking research in P-type ATPases and neuroscience from Aarhus University to propose a novel disease-modifying treatment for patients suffering from Parkinson's Disease and associated disorders. By targeting the SERCA calcium transporter, our first-in-class small molecules salvage the root disease cause by repairing the neuronal calcium imbalances caused by pathological α-Synuclein brain species.

77 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Targeting CCN signaling to treat fibrosis Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

120 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Specializing in Therapeutic Video Games and Digital Medical Devices. We specialize in Therapeutic Video Games and Digital Medical Devices. Co-founder of LabCom BRAIN e-NOVATION with the Brain and Spinal Cord Institute.

63 similar entities Type: Startup Activities: games healthtech Technologies: Synthetic Biology

Software, Machines and Adaptive Implants in Orthopaedics SMAIO (Software, Machines and Adaptive Implants in Orthopaedics) is a medical device manufacturer founded in 2009 by a group of spine surgeons having extensive experience in spinal pathologies treatment and a particular focus on patient sagittal balance restoration. SMAIO aims to provide surgeons with integrated spinal solutions (software, implants, services, instruments, etc.).

59 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Peptide-based therapeutics for treating peripheral pain conditions At Akasi Pharma, we are developing novel peptide-based therapeutics to treat peripheral pain conditions Peptide therapeutics and Peripheral Neuropathic Pain

109 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Un ingrédient alimentaire innovant à base de clou de girofle pour la santé cognitive Aroma Therapeutics is a biotech company specialised in natural products for the prevention of brain diseases. Aroma Therapeutics has patented a scent diffusion technology for Olfactory Deep-Brain stimulation. In collaboration with well-known laboratories, the company is working on an ethno-botanical approach for : •babie's pain relief •memory improvement and prevention of Alzheimer Disease The company also provides tools for Brain Function & Sleep Enhancement. Santé, Aromathérapie, Phytothérapie, Extraction de plantes, Compléments alimentaires, Santé Cognitive, Senior, Nutraceutique, maladies du vieillissement, alzheimer, Médecine Traditionnelle Chinoise, and Nutraceutique

84 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Unlocking the therapeutic potential of protein stabilisation Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.

140 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A new hope for patients affected by Alzheimer’s disease CaSRevolution is a research company specialized in devising innovative therapies for neurodegeneration diseases We have discovered a new mechanism that explains the progression of Alzheimer’s Disease and identified a potential therapeutic approach biotech, neurodegeneration, startup, and alzheimer

129 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.

146 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Reversing Neurodegeneration - Restoring Life GeneCode is developing small-molecule drugs that bind and activate GDNF (Glial cell line-Derived Neurotrophic Factor) receptors for the treatment of Parkinson’s disease (PD) and other neurodegenerative conditions.

119 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Medical solutions PD Neurotechnology Ltd is a high-tech medical device company, founded in London, UK. The Greek Branch is based in Athens, Greece and the main activity of the company is carried out in the R&D and production, which is located in Ioannina, Greece. The company focuses its activities on researching, developing, producing and selling wearable medical devices and solutions for monitoring and supporting treatment of movement disorders. Its first solution is PDMonitor which is a sophisticated expert eco-system for patients with Parkinson’s Disease.

103 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Nanovery - experts in nucleic acid quantification using nanorobots. We have created a proprietary Nucleic Acid Nanorobotics (NANs) platform that simplifies molecular testing and quantification for RNA therapeutics and biomarkers.

77 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Soft Minimally Invasive Brain Computer Interfaces At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.

65 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

310 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advancing the state-of-the-art in nature-based healthcare solutions Adamas Biotech exploits its core area of know-how, namely the anti-inflammatory, antioxidant and analgesic properties of green tea catechins to develop nutraceuticals and related products in the field of lower urinary tract symptoms and gastroenterology.

131 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Revolutionizing drug delivery HHC medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation. Drug Delivery, Genetic therapies, and Enabling life-altering therapies

296 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

THERADEV, a Deeptech start-up recognized by BpiFrance, is a Biotech company specializing in the research and development of innovative solutions linked to the main metabolic disorders in humans.

58 similar entities Type: Startup Activities: deeptech

Medical device company developing newborn brain monitoring solutions. Neurobell develop novel products for early detection and monitoring of neonatal seizures to facilitate better treatment and patient outcomes.

63 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

NeoDynamics was a publicly listed medical device company specializing in breast cancer diagnostics. Its flagship product, the NeoNavia Biopsy System, was acquired by NeoNavia AB. Following this transaction, NeoDynamics AB (publ) now operates under the name Gardienne Invest AB (publ).

59 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Delivering longer, better quality lives for brain tumour patients QV Bioelectronics is a VC-backed medical device startup developing an implantable electric field therapy treatment for aggressive brain tumours.

114 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception. medical device, biotechnology, urology, contraception, womenshealth, reproductivehealth, and menshealth

252 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Secuderm, revolutionary skin protection technology: validated by Navy doctors on swimmers in immersion, now makes it possible to secure a treatment or a device and free the patient Secuderm, unique and revolutionary technology which secures a care (device, cream..) and frees the patient.

59 similar entities Type: SMB Activities: deeptech healthtech

Making Regenerative Medicine Accessible Roumai Medical is developing next-generation biotechnologies in regenerative medicine and human-machine interface to meet the unmet clinical needs of millions of patients worldwide.

207 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The Observatory of Medicines 💊, Medical Devices 💉 and Therapeutic Innovation 🔬 OMEDIT Pays de la Loire is a support and expertise structure at the regional level in the field of Medicines, Medical Devices and Therapeutic Innovation.

110 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

535 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AstronauTx is developing therapeutics to treat neurological disorders by improving sleep architecture. At AstronauTx our thesis is that changes in sleep architecture underpin disease and that sleep is a modifiable risk factor for chronic neurodegeneration. We have a unique portfolio of small-molecule therapeutics to restore dysregulated sleep physiology correcting sleep architecture to both improve symptoms and modify neurological disease progression.

61 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

In vitro Slice Electrophysiology for CNS and Pain Research Neuroservice USA has been acquired by Neuroservices Alliance Please visit: https://www.linkedin.com/company/18799325 Drug Discovery, CNS, Electrophysiology, Pharmacology, Multi-Electrode Array, Patch-Clamp, Pain, Brain slices recordings, Safety, Toxicology, Neuropharmacology, CNS Research, CNS Preclinical Research, Preclinical Research, and CNS Electrophysiology

139 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system. Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies. CNS

74 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Improving cancer treatment through neurological screening With Wenemea solution chemotherapy induced peripheral neuropathy (CIPN) can be monitored easier, leading to earlier action, including improved medication and improved quality of life for breast cancer patients

60 similar entities Type: Startup Activities: deeptech healthtech

The NeuroPace RNS System is the only brain-responsive neurostimulation system for refractory focal epilepsy. Rx Only. The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting …

67 similar entities Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

The Anti-Nausea Wristband helping you overcome life's uncomfortable moments. Reliefband® is a world leader in neuromodulation creating the first FDA-cleared, clinically proven wearable device that treats nausea and vomiting associated with sea sickness, motion sickness, migraines, anxiety, and more. Worn on the wrist, Reliefband's patented technology stimulates a nerve that sends a message to the brain to "turn off" nausea, providing quick and effective relief without any unwanted side effects.

59 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Innovating with AI and nanotechnology to develop more effective health products in less time NanotheraTM is a startup that offers innovative solutions in R&D (Design/Nanoformulation) intended for parapharmaceutical and pharmaceutical laboratories. We combine AI and nanotechnology for more effective therapeutic solutions in less time. nanotechnology, Nutraceuticals, and Artificial Intelligence

77 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Overcoming Barriers in Treatment-Resistant Depression FundaMental Pharma is engaged in pioneering research on a novel type of dual-acting modulators of the N-methyl-D-aspartate receptor (NMDAR) for treatment-resistant depression (TRD): • NMDAR/TRPM4 complex disruption modulates extrasynaptic NMDAR signaling, thereby boosting antidepressant efficacy and providing neuroprotection • NMDAR antagonism represents a clinically validated antidepressive mechanism of action with rapid onset and substantial efficacy in TRD patients FundaMental Pharma’s clinical candidate FMP374 is a dual-acting molecule with a higher affinity for the NMDA receptor than the current standard of care esketamine and is orally bioavailable. Our preclinical data highlight the extraordinary profile of FMP374 …

63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

health technologies for everyone Interrupt Engineering is a medical device company known for its innovative products, including MoveMate, a wearable health technology designed to detect freezing of gait, a movement disorder commonly seen in Parkinson's patients. biyomedikal, elektronik, and medikal cihaz

236 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

33 years of clinical research in pharmacy, medical device & amp; Dermo-cosmetics Quanta Medical Sharing experience Cro since 1986. 30 years of advice and operational services in clinical research and observational studies, 30 years of presence in Europe and on the African continent alongside the pharmaceutical, agro-food, dermatological, cosmetics and medical device, 30 years of human health know -how reinforced by: - a double ISO 9001 & amp; 27001 -dedicated technical tools (Quanta View®, E-CRF, Trial-on-Line®) Clinical research / Clinical trial, E-CRF, Epidemiological Study, Data Management / Biometrics, Medical Writing, Health IT development, Evaluation of health risks, and regulatory advice

467 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Changing the paradigm in Friedreich's ataxia Biointaxis is an academic spin-off focused on the development of gene therapies for neurodegenerative disorders. Biointaxis lead product is a gene therapy product for Friedreich ataxia.

59 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Sustainable circular-derived protein | Clean-label ingredients for alt-protein & cultivated meat | High Quality Cells An ingredients company providing sustainable, scalable and delicious solutions for alternative protein and cultured meat.

70 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

CardioScale is an Israeli medical device start-up founded 2012, pursuing a novel patent applied diagnostic for early detection of cardiovascular deterioration in various patients of heart failure and shock.

139 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Transforming Energy into Therapy Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. medical device, COPD, AF, Oncology, Intervential Oncology, Intervential Pulmonology, AFib, PEF, PEF Ablation, Soft Tissue Ablation, Cardiac Arrhythmias, and Chronic Bronchitis

451 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc...

132 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The standard-bearer for scientifically-proven tinnitus treatment. Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as …

95 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Delivering Hope to the Heart of our Patients AuriGen Medical are an EUeic supported medical device start up, developing the next generation in left atrial appendage implant technology for the treatment of medication resistant longstanding persistent atrial fibrillation. #EUeic #eicAccelerator

93 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Elevating dermatologic care with a non-invasive skin genomics platform technology. DermTech 2.0 provides genomic analysis of skin samples collected non-invasively using its proprietary Smart Sticker platform technology. DermTech 2.0 develops and markets products to facilitate the assessment of melanoma, including the DermTech Melanoma Test, and offers DermTech Stratum, a precision biomarker service offering for biopharmaceutical and research partners. Melanoma, Gene Expression Testing, Pigmented Lesions, Dermatology, Dermatopathology, Clinical Trial Support, Clinical Trial Testing, Clinical Tissue Bank, and Genomics

62 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

A multi-expertise approach tackling the non-invasive challenge Eclypia, driven by excellence, prones a multi-expertise global approach to tackle technological, physiological and algorithmic challenges.

62 similar entities Type: SMB Activities: deeptech

Developing first in class therapies for the treatment of dementia. Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as frontotemporal dementia (FTD) and Alzheimer’s disease (AD) to improve patients’ quality of life and reduce the burden of disease on their families, providers, and the overall healthcare system. Our immediate goal is to develop a peptide-based compound, CT-526, for FTD. neurodegeneration, neuropeptide, frontotemporal dementia, Alzheimer's disease, and progressive supranuclear palsy

102 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology